(Q77899321)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9916609%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

title

Amlodipine, felodipine, and isradipine in the treatment of Chinese patients with mild-to-moderate hypertension (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9916609%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

author name string

B M Cheung

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9916609%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

C P Lau

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9916609%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

B Z Wu

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9916609%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

publication date

1 November 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9916609%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

published in

Clinical Therapeutics

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9916609%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9916609%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9916609%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

page(s)

1159-1169

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9916609%20AND%20SRC:MED&resulttype=core&format=json

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

9 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980111-2

7 January 2021

Management guidelines in essential hypertension: report of the second working party of the British Hypertension Society

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980111-2

7 January 2021

Clinical studies of drug reversal of hypertensive left ventricular hypertrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980111-2

7 January 2021

Comparison of enalapril and nifedipine in treating non-insulin dependent diabetes associated with hypertension: one year analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980111-2

7 January 2021

Isradipine in essential hypertension: the Belgian General Practitioners' Study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980111-2

7 January 2021

Comparison of early side effects with amlodipine and nifedipine retard in hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980111-2

7 January 2021

Amlodipine compared to nitrendipine in hypertensive patients: the effects on toleration in relationship to the onset of action

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980111-2

7 January 2021

Felodipine, a new calcium antagonist, as monotherapy in mild or moderate hypertension. Cooperative study group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980111-2

7 January 2021

Short and long term treatment of essential hypertension with felodipine as monotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980111-2

7 January 2021

Antihypertensive activity of isradipine in humans: a new dihydropyridine calcium channel antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980111-2

7 January 2021

Multicenter evaluation of the safety and efficacy of isradipine in hypertension. The Italian-Belgian Isradipine Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980111-2

7 January 2021

Calcium antagonists in hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980111-2

7 January 2021

Felodipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980111-2

7 January 2021

Dose-response relationship and incidence of adverse drug reactions with isradipine in patients with essential hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980111-2

7 January 2021

Relative efficacy and tolerability of lacidipine and amlodipine in patients with mild-to-moderate hypertension: a randomized double-blind study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980111-2

7 January 2021

Salt and blood pressure responses to calcium antagonism in hypertensive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980111-2

7 January 2021

A comparative assessment of amlodipine and felodipine ER: pharmacokinetic and pharmacodynamic indices

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980111-2

7 January 2021

Shanghai trial of nifedipine in the elderly (STONE)

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980111-2

7 January 2021

Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980111-2

7 January 2021